Abstract
BackgroundAcute ischemic stroke is a leading cause of mortality and morbidity throughout the world. Thrombolysis with intravenous tissue plasminogen activator (tPA) is often the first-line therapy after presentation. For select...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
